GlaxoSmithKline VP of Finance Salaries in New York | Comparably
"GlaxoSmithKline discovers, develops and manufactures pharmaceuticals, vaccines and consumer healthcare products." read more
EMPLOYEE
PARTICIPANTS
39
TOTAL
RATINGS
383

GlaxoSmithKline VP of Finance Salaries in New York

The average GlaxoSmithKline VP of Finance in New York earns an estimated $135,176 annually. GlaxoSmithKline's VP of Finance compensation is $71,354 less than the US average for a VP of Finance.

In New York, The Finance Department at GlaxoSmithKline earns $23,899 more on average than the Admin Department.

Last updated 2 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$135,176
Average Compensation
$135,176
avg. base

VP of Finance Salaries at GlaxoSmithKline

In New York, VPs of Finance earn $31,496 more than Accounting Managers.

Accounting Manager
$104k*
Business Analyst
$97k*
Senior Accountant
$93k*
Financial Analyst
$91k*
Accountant
$68k*
* estimated salary

Compensation at GlaxoSmithKline by Department

In New York, The Finance Department averages $23,899 more than the Admin Department, and $3,823 less than the Design Department

Design
$90,446 Avg. total comp.
+$4k
Finance
$86,623 Avg. total comp.
Admin
$62,724 Avg. total comp.
-$24k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to GlaxoSmithKline reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to GlaxoSmithKline reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at GlaxoSmithKline Rate Their Compensation

The majority of VPs of Finance at GlaxoSmithKline believe they're compensated fairly. 100% of VPs of Finance at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline

×
Rate your company